Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
Relapses in multiple sclerosis: effects of high-dose steroids on cortical excitability.
OCT: New perspectives in neuro-ophthalmology.
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
Human endogenous retrovirus-K contributes to motor neuron disease.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
The POLG Polyglutamine Tract Variants in Iranian Patients with Multiple Sclerosis.
Moyamoya disease in a patient with neuromyelitis optica.
Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Methionyl-tRNA Formyltransferase (MTFMT) Deficiency Mimicking Acquired Demyelinating Disease.
Psychiatric morbidity in patients with transverse myelitis and stroke: A comparison.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
Advanced Joystick Algorithms for Computer Access Tasks.
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
["Time is brain" in relapsing remitting multiple sclerosis : Current treatment concepts in immunotherapy].
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Vigabatrin-induced CNS changes in juvenile rats: Induction, progression and recovery of myelin-related changes.
[Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.]
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes.
Pages
« first
‹ previous
…
509
510
511
512
513
514
515
516
517
…
next ›
last »